Vanguard Group Inc Novavax Inc Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Novavax Inc stock. As of the latest transaction made, Vanguard Group Inc holds 15,726,250 shares of NVAX stock, worth $125 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,726,250

Previous 15,430,069 1.92%

Holding current value

$125 Million

Previous $195 Million 35.12%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$7.22 - $14.68 $2.14 Million - $4.35 Million	296,181 Added 1.92%	15,726,250 $126 Million
Q3 2024 Nov 13, 2024	BUY	$10.71 - $17.11 $14.5 Million - $23.2 Million	1,354,696 Added 9.62%	15,430,069 $195 Million
Q2 2024 Aug 13, 2024	BUY	$3.89 - $20.97 $2.26 Million - $12.2 Million	582,099 Added 4.31%	14,075,373 $178 Million
Q1 2024 May 10, 2024	SELL	$3.76 - $6.02 $4.01 Million - $6.42 Million	-1,066,787 Reduced 7.33%	13,493,274 $64.5 Million
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $14.4 Million - $23.1 Million	3,008,585 Added 26.05%	14,560,061 $69.9 Million
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $6.67 Million - $9.53 Million	978,873 Added 9.26%	11,551,476 $83.6 Million
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $2.53 Million - $3.6 Million	378,645 Added 3.71%	10,572,603 $78.6 Million
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $7.77 Million - $16.8 Million	1,349,305 Added 15.26%	10,193,958 $70.6 Million
Q4 2022 Feb 10, 2023	BUY	$8.86 - $25.04 $11.9 Million - $33.8 Million	1,348,729 Added 17.99%	8,844,653 $90.9 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $2.64 Million - $11 Million	144,999 Added 1.97%	7,495,924 $136 Million
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $13.9 Million - $28.9 Million	383,982 Added 5.51%	7,350,925 $378 Million
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $4.88 Million - $9.99 Million	69,936 Added 1.01%	6,966,943 $513 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $13.5 Million - $21.8 Million	100,009 Added 1.47%	6,897,007 $987 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $22.5 Million - $34.2 Million	126,338 Added 1.89%	6,796,998 $1.41 Billion
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $807 Million - $1.72 Billion	6,670,660 New	6,670,660 $1.42 Billion

Others Institutions Holding NVAX

# of Institutions

285

Shares Held

93.8M

Call Options Held

5.4M

Put Options Held

8.76M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $619M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Novavax Inc Transaction History